Hepatitis c care at opioid clinics boosts treatment access
NCT ID NCT03155906
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tested whether offering hepatitis C treatment at the same clinic where people receive opioid therapy leads to better outcomes than referring them to a separate infectious disease clinic. About 298 people on opioid therapy with chronic hepatitis C took part. The goal was to see if integrated care increases the number of people cured and improves treatment adherence.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Integrated healthcare delivery (HCV treatment at opioid substitution therapy clinics)
What this could lead to
If this approach works, it could make hepatitis C treatment much easier for people on opioid therapy, leading to higher cure rates and fewer new infections.
What could go wrong
This is a completed trial, but the integrated model may not work in all settings or for all patients. Also, reinfection remains a risk if drug use continues.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATITIS C, CHRONIC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Department of Addiction Medicine, Haukeland University Hospital
Bergen, Hordaland, 5020, Norway
-
LAR Helse Stavanger HF
Stavanger, Rogaland, 4010, Norway